By employing peptide-based strategies to inhibit anti-apoptotic proteins like BCL-2, programmed cell Loss of life is often induced in most cancers cells, finally leading to their demise. These specific methodologies exhibit encouraging results in augmenting the success of cancer therapy and boosting